About Us
Trinity Life Sciences provides a range of integrated, evidence-based solutions specifically designed and deployed for life sciences companies.
With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making.
Trinity is humbled to work with over 300 active clients, including the top 35 biopharma companies in the world, as well as dozens of leading medical device, diagnostic and related companies. In 2023, the company worked on 75% of all new drug launches and provides ongoing, in-depth, high value thought leadership that helps shape the industry.
With 1300 employees and 11 offices around the globe, Trinity continues to grow both organically and through acquisitions. These acquisitions included BluePrint Research Group, CBPartners, TGaS Advisors, Bell Canyon and D Cube Analytics, the latter of which dramatically leap-frogged Trinity to the leading provider of go-to-market analytics and AI to biopharma companies. Trinity has also entered into transformative partnerships with Bain & Company and Havas Health & You that have strategically advanced Trinity’s mission to revolutionize the pharmaceutical commercial model.
Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits.